ATE267194T1 - Medikamente geeignet zur behandlung von proliferativen erkrankungen - Google Patents

Medikamente geeignet zur behandlung von proliferativen erkrankungen

Info

Publication number
ATE267194T1
ATE267194T1 AT00989233T AT00989233T ATE267194T1 AT E267194 T1 ATE267194 T1 AT E267194T1 AT 00989233 T AT00989233 T AT 00989233T AT 00989233 T AT00989233 T AT 00989233T AT E267194 T1 ATE267194 T1 AT E267194T1
Authority
AT
Austria
Prior art keywords
treatment
proliferative diseases
medications suitable
medications
proliferative
Prior art date
Application number
AT00989233T
Other languages
English (en)
Inventor
Rima Salim Al-Awar
Kyle Andrew Hecker
Jianping Huang
Sajan Joseph
James Edward Ray
Philip Parker Waid
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE267194T1 publication Critical patent/ATE267194T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00989233T 1999-12-16 2000-12-18 Medikamente geeignet zur behandlung von proliferativen erkrankungen ATE267194T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17126999P 1999-12-16 1999-12-16
US17121999P 1999-12-16 1999-12-16
PCT/US2000/033274 WO2001044235A2 (en) 1999-12-16 2000-12-18 Agents and methods for the treatment of proliferative diseases

Publications (1)

Publication Number Publication Date
ATE267194T1 true ATE267194T1 (de) 2004-06-15

Family

ID=26866852

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00989233T ATE267194T1 (de) 1999-12-16 2000-12-18 Medikamente geeignet zur behandlung von proliferativen erkrankungen

Country Status (6)

Country Link
EP (1) EP1250334B1 (de)
AT (1) ATE267194T1 (de)
AU (1) AU2576901A (de)
DE (1) DE60010934T2 (de)
ES (1) ES2220585T3 (de)
WO (1) WO2001044235A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312154C (zh) 2002-03-05 2007-04-25 伊莱利利公司 作为激酶抑制剂的嘌呤衍生物
IL163777A0 (en) 2002-03-08 2005-12-18 Lilly Co Eli Kinase inhibitors
DE602006017965D1 (de) 2005-02-09 2010-12-16 Arqule Inc Maleimid-derivate, pharmazeutische zusammensetzungen und verfahren zur behandlung von krebs
US8304425B2 (en) * 2007-06-22 2012-11-06 Arqule, Inc. Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
KR20100024494A (ko) 2007-06-22 2010-03-05 아르퀼 인코포레이티드 퀴나졸리논 화합물 및 이의 사용 방법
CA2690782C (en) 2007-06-22 2016-02-02 Arqule, Inc. Compositions and methods for treatment of cancer
WO2011082266A2 (en) 2009-12-30 2011-07-07 Arqule, Inc. Substituted heterocyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE456367T1 (de) * 1993-12-23 2010-02-15 Lilly Co Eli Proteinkinase c inhibitoren
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos

Also Published As

Publication number Publication date
DE60010934T2 (de) 2005-05-19
DE60010934D1 (de) 2004-06-24
EP1250334A2 (de) 2002-10-23
EP1250334B1 (de) 2004-05-19
WO2001044235A2 (en) 2001-06-21
AU2576901A (en) 2001-06-25
ES2220585T3 (es) 2004-12-16
WO2001044235A3 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
ATE316785T1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE50310516D1 (de) Fredericamycin-derivate
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE266031T1 (de) Verfahren und verbindungen zur behandlung proliferativer erkrankungen
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
ATE367380T1 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
ATE265455T1 (de) Tetrahydropyridoverbindungen
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE320255T1 (de) Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen
DE69930844D1 (de) Inhibitoren von mycobakterien
DE60229047D1 (de) Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit
ATE344666T1 (de) Pyridin-2-yl-methylamin-derivate zur behandlung von opiatsucht
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
EP1244467A4 (de) Phospholglyerat-kinase zur behandlung von krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties